Patrick Donnelly Analyst PerformanceManaging Director, Equity Research at CitigroupPatrick Donnelly is a stock analyst at Citigroup focused in the medical sector, covering 24 publicly traded companies. Over the past year, Patrick Donnelly has issued 53 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Patrick Donnelly's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Patrick Donnelly's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings67 Last 4 YearsBuy Recommendations50.00% 33 Buy RatingsCompanies Covered24 Unique Companies Ratings Distribution66RatingsDistribution of strong buy, buy, hold, and sell ratings by Patrick Donnelly.RatingPercentageCount Strong Buy1.5%1 ratings Buy48.5%32 ratings Hold45.5%30 ratings Sell4.5%3 ratingsOut of 66 total stock ratings issued by Patrick Donnelly at Citigroup, the majority (48.5%) have been Buy recommendations, followed by 45.5% Hold, 4.5% Sell, and 1.5% Strong Buy.Best & Worst CallsBest Call0000.0%TXGMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ICLRApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ54.2% of companies on NASDAQ13 companiesNYSE45.8% of companies on NYSE11 companiesPatrick Donnelly, an analyst at Citigroup, currently covers 24 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical21 companies87.5%Services1 company4.2%Computer and Technology1 company4.2%Manufacturing1 company4.2%Patrick Donnelly of Citigroup specializes in stock coverage within the Medical sector, with additional focus on Services and Computer and Technology companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES6 companies25.0%MED - BIOMED/GENE5 companies20.8%MED INSTRUMENTS4 companies16.7%MED PRODUCTS3 companies12.5%SERVICES – HEALTH1 company4.2%INSTRU - SCIENTFC1 company4.2%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company4.2%MEDICAL INFO SYS1 company4.2%MED - DRUGS1 company4.2%MED - OUTP/HM CRE1 company4.2% Patrick Donnelly's Ratings History at Citigroup Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsQGENQiagen5/18/2026Reiterated Rating$33.00Hold$0.0000.00% ROICAICaris Life Sciences5/8/2026Lower Price Target$16.15$28.00Buy$0.0000.00% ROIMTDMettler-Toledo International5/8/2026Lower Price Target$1,123.08$1,550.00Buy$0.0000.00% ROIBRKRBruker5/7/2026Boost Price Target$42.30$44.00Neutral$0.0000.00% ROIMDLNMedline5/7/2026Lower Price Target$42.01$55.00Buy$0.0000.00% ROITECHBio-Techne5/7/2026Lower Price Target$50.91$70.00Buy$0.0000.00% ROIFTREFortrea5/6/2026Boost Price Target$14.53$20.00Buy$0.0000.00% ROIQDELQuidelOrtho5/6/2026Lower Price Target$11.09$13.00Neutral$0.0000.00% ROIILMNIllumina5/4/2026Boost Price Target$135.78$95.00Sell$0.0000.00% ROIAVTRAvantor4/30/2026Lower Price Target$8.09$9.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. QGENQiagen4/29/2026Lower Price Target$33.31$38.00Neutral$0.0000.00% ROIBIOBio-Rad Laboratories4/7/2026Downgrade$278.96$300.00Neutral$0.0000.00% ROITXG10x Genomics4/7/2026Boost Price Target$21.71$24.00Neutral$0.0000.00% ROIMDLNMedline3/11/2026Initiated Coverage$42.76$60.00Buy$0.0000.00% ROIICLRIcon3/11/2026Lower Price Target$104.76$120.00Neutral$0.0000.00% ROISTVNStevanato Group3/5/2026Lower Price Target$16.03$26.00Buy$0.0000.00% ROIMDLNMedline2/26/2026Boost Price Target$49.56$60.00Buy$0.0000.00% ROISHCSotera Health2/24/2026Boost Price Target$16.73$23.00Buy$0.0000.00% ROIGHGuardant Health2/20/2026Boost Price Target$106.38$150.00Buy$0.0000.00% ROIBRKRBruker2/13/2026Lower Price Target$37.51$40.00Neutral$0.0000.00% ROIAVTRAvantor2/12/2026Lower Price Target$9.66$11.00Neutral$0.0000.00% ROIQDELQuidelOrtho2/12/2026Boost Price Target$28.80$30.00Neutral$0.0000.00% ROIDGXQuest Diagnostics2/10/2026Boost Price Target$203.42$215.00Neutral$0.0000.00% ROIQGENQiagen2/6/2026Lower Price Target$51.26$55.00Neutral$0.0000.00% ROIIQVIQVIA2/6/2026Lower Price Target$187.48$200.00Neutral$0.0000.00% ROITECHBio-Techne2/4/2026Reiterated Rating$68.77$80.00Buy$0.0000.00% ROITMOThermo Fisher Scientific1/30/2026Boost Price Target$593.16$685.00Buy$0.0000.00% ROICRLCharles River Laboratories International1/16/2026Boost Price Target$223.15$265.00Buy$0.0000.00% ROIBRKRBruker1/16/2026Boost Price Target$49.44$53.00Neutral$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$42.22$48.00Buy$0.0000.00% ROINTRANatera1/7/2026Initiated Coverage$248.74$300.00Buy$0.0000.00% ROINTRANatera1/7/2026Upgrade$234.31Strong-Buy$0.0000.00% ROITXG10x Genomics12/11/2025Downgrade$16.54Cautious$0.0000.00% ROIGHGuardant Health12/11/2025Boost Price Target$102.62$135.00Buy$0.0000.00% ROITMOThermo Fisher Scientific12/11/2025Upgrade$574.19$660.00Buy$0.0000.00% ROIQGENQiagen12/11/2025Downgrade$48.06$52.63Neutral$0.0000.00% ROIFTREFortrea12/11/2025Upgrade$15.14$21.00Buy$0.0000.00% ROITXG10x Genomics12/11/2025Reiterated Rating$17.53$18.00Neutral$0.0000.00% ROIAAgilent Technologies11/25/2025Boost Price Target$157.58$185.00Buy$0.0000.00% ROIMTDMettler-Toledo International11/10/2025Boost Price Target$1,433.54$1,700.00Buy$0.0000.00% ROIYour $29.97 book is free today (Ad)Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.Normally $29.97. Today it's free. Grab your copy now.GHGuardant Health10/30/2025Boost Price Target$92.96$100.00Buy$0.0000.00% ROIBIOBio-Rad Laboratories10/30/2025Boost Price Target$308.64$375.00Buy$0.0000.00% ROIIQVIQVIA10/29/2025Boost Price Target$218.26$230.00Neutral$0.0000.00% ROITMOThermo Fisher Scientific10/23/2025Boost Price Target$568.42$580.00Neutral$0.0000.00% ROIQDELQuidelOrtho10/7/2025Reiterated Rating$29.60$33.00Neutral$0.0000.00% ROIICLRIcon8/21/2025Reiterated Rating$180.25$200.00Neutral$0.0000.00% ROITECHBio-Techne8/21/2025Upgrade$54.33$70.00Buy$0.0000.00% ROIMTDMettler-Toledo International8/21/2025Boost Price Target$1,302.25$1,600.00Buy$0.0000.00% ROIQDELQuidelOrtho8/6/2025Lower Price Target$23.44$40.00Buy$0.0000.00% ROIBRKRBruker8/4/2025Lower Price Target$34.72$38.00Neutral$0.0000.00% ROIHOLXHologic7/9/2025Upgrade$64.90$80.00Buy$0.0000.00% ROIILMNIllumina7/9/2025Downgrade$99.27$80.00Strong Sell$0.0000.00% ROIBRKRBruker5/22/2025Downgrade$36.45$40.00Hold$0.0000.00% ROIBIOBio-Rad Laboratories5/2/2025Lower Price Target$236.83$350.00Buy$000.0000.00% ROIICLRIcon4/7/2025Lower Price Target$150.81$215.00Buy$000.0000.00% ROIBRKRBruker4/7/2025Lower Price Target$38.21$50.00Buy$00.0000.00% ROIDGXQuest Diagnostics3/4/2025Downgrade$176.81$185.00Neutral$000.0000.00% ROITMOThermo Fisher Scientific3/4/2025Lower Price Target$516.21$570.00Neutral$000.0000.00% ROITXG10x Genomics3/4/2025Lower Price Target$10.32$15.00Buy$00.0000.00% ROIAVTRAvantor3/4/2025Lower Price Target$15.53$18.00Neutral$0.0000.00% ROITECHBio-Techne3/4/2025Lower Price Target$60.00$70.00Neutral$00.0000.00% ROIIQVIQVIA3/4/2025Lower Price Target$183.94$210.00Neutral$000.0000.00% ROITXG10x Genomics2/13/2025Lower Price Target$11.35$20.00Buy$00.0000.00% ROITMOThermo Fisher Scientific1/31/2025Boost Price Target$598.16$650.00Neutral$000.0000.00% ROIDHRDanaher1/30/2025Lower Price Target$223.16$265.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
